Hanson & Doremus Investment Management Purchases 77 Shares of Xylem Inc. $XYL

Hanson & Doremus Investment Management grew its stake in Xylem Inc. (NYSE:XYL) by 0.9% during the second quarter, Holdings Channel.com reports. The fund owned 8,516 shares of the industrial products company’s stock after purchasing an additional 77 shares during the quarter. Hanson & Doremus Investment Management’s holdings in Xylem were worth $1,102,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC lifted its position in shares of Xylem by 8.4% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 52,401 shares of the industrial products company’s stock worth $6,080,000 after purchasing an additional 4,052 shares during the period. Versant Capital Management Inc lifted its position in shares of Xylem by 536.1% in the 1st quarter. Versant Capital Management Inc now owns 2,341 shares of the industrial products company’s stock worth $280,000 after purchasing an additional 1,973 shares during the period. GAMMA Investing LLC lifted its position in shares of Xylem by 15,322.5% in the 1st quarter. GAMMA Investing LLC now owns 506,630 shares of the industrial products company’s stock worth $60,522,000 after purchasing an additional 503,345 shares during the period. Fifth Third Wealth Advisors LLC boosted its stake in Xylem by 5.4% in the first quarter. Fifth Third Wealth Advisors LLC now owns 2,206 shares of the industrial products company’s stock valued at $264,000 after acquiring an additional 113 shares in the last quarter. Finally, Rhumbline Advisers boosted its stake in Xylem by 6.4% in the first quarter. Rhumbline Advisers now owns 450,736 shares of the industrial products company’s stock valued at $53,845,000 after acquiring an additional 27,046 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Trading Up 1.1%

NYSE:XYL opened at $143.03 on Monday. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $145.33. The firm has a fifty day simple moving average of $140.36 and a 200-day simple moving average of $128.64. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $34.82 billion, a P/E ratio of 37.15, a PEG ratio of 2.47 and a beta of 1.09.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. During the same period in the previous year, the firm posted $1.09 earnings per share. The business’s revenue for the quarter was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, equities research analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem’s dividend payout ratio (DPR) is 41.56%.

Insider Activity

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the transaction, the chief accounting officer owned 2,957 shares of the company’s stock, valued at $413,861.72. This trade represents a 25.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.27% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

XYL has been the subject of several recent analyst reports. Stifel Nicolaus raised their target price on shares of Xylem from $162.00 to $175.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Barclays initiated coverage on shares of Xylem in a research note on Friday, September 19th. They issued an “overweight” rating and a $165.00 target price for the company. Wall Street Zen upgraded shares of Xylem from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. Citigroup restated a “buy” rating and issued a $152.00 target price (up from $137.00) on shares of Xylem in a research note on Monday, July 14th. Finally, Zacks Research upgraded shares of Xylem from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 22nd. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Xylem presently has a consensus rating of “Moderate Buy” and a consensus price target of $152.33.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.